Erkut Borazanci, MD, MS, is a medical oncologist specializing in gastrointestinal oncology. He serves as Medical Director of the Oncology Research Division at HonorHealth Research Institute in Scottsdale and is a clinical investigator at the Virginia G. Piper Cancer Center, where he also leads the Molecular Medicine Institute. He additionally holds adjunct faculty appointments with TGen (City of Hope) and the University of Arizona College of Medicine – Phoenix. His clinical focus centers on gastrointestinal cancer care, early-phase therapeutic trials, and precision oncology guided by molecular profiling. Dr. Borazanci’s research interests include first-in-human and early-phase drug development, translational genomics and biomarker-driven treatment strategies, and blood-based approaches to earlier cancer detection. He is known for an “institute without walls” approach that emphasizes collaboration across academic teams, community practices, and advocacy partners to accelerate the translation of discoveries into patient-accessible therapies. His achievements include recognition as a MediFind “Top 10 Elite Expert” for work in gastrointestinal oncology, the Purple Pansies Bill Palmer Legacy Award, and the HonorHealth Physician Leadership Award for Citizenship and Community Service. He also serves on the Pancreatic Medical Advisory Board for Vivacitas Oncology and collaborates internationally on multi-institutional research initiatives. Dr. Borazanci earned his MD from LSU Health Shreveport, completed an internal medicine residency at LSU Medical Center–University Hospital/Ochsner LSU Health, and finished fellowship training in hematology and oncology at LSU Health Shreveport.
Director Oncology
2013 – present
Medical School
2004 – 2008
Residency
2008 – 2011
Fellowship
2011 – 2013